Community Pharmacy England News

- 4TH DECEMBER 2024
- 0 COMMENTS
MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited)
MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) Drug alert number: EL (24)A/61 Date issued: 4 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited) DMRC reference number:DMRC-34033472 Company
Read more
- Community Pharmacy England News
- 3RD DECEMBER 2024
- 0 COMMENTS
Community Pharmacy England submits proposals for NHS 10-Year Plan
Community Pharmacy England has made a submission to the Government’s development of a 10-year Health Plan for the NHS, highlighting the benefits of increased commissioning of pharmacy services in tandem with addressing the sector’s current funding gap. In October, the Secretary of State for Health and Social Care launched a national conversation on the NHS, seeking
Read more
- Community Pharmacy England News
- 3RD DECEMBER 2024
- 0 COMMENTS
November 2024 Price Concessions Final Update
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (03/12/2024) announced the following final list of price concessions for November 2024: Please note these prices only apply to prescriptions submitted as dispensed in November 2024. Community Pharmacy
Read more
- Community Pharmacy England News
- 3RD DECEMBER 2024
- 0 COMMENTS
MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK)
MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) Drug alert number: EL (24)A/60 Date issued: 3 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) DMRC reference number: DMRC-31179592 Company name:
Read more
- Community Pharmacy England News
- 3RD DECEMBER 2024
- 0 COMMENTS
Medicine Supply Notification: Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo MSN/2024/111 Tier 2 – medium impact Date of issue: 3rd December 2024 Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo (all pack sizes) is being discontinued from February 2025 Alternative coal tar extract
Read more
- Community Pharmacy England News
- 2ND DECEMBER 2024
- 0 COMMENTS
Explained: the introduction of Original Pack Dispensing
Community Pharmacy England has released a set of resources to explain the introduction of Original Pack Dispensing (OPD), including how and when it will apply. From 1st January 2025, amendments made to the pharmacy regulations state that the supervising pharmacist must consider dispensing up to 10% more or less than the prescribed quantity, as appropriate,
Read more
- Community Pharmacy England News
- 2ND DECEMBER 2024
- 0 COMMENTS
MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited)
MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) Drug alert number: EL (24)A/59 Date issued: 2 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) DMRC reference number: DMRC-33616486 Company name:
Read more
- Community Pharmacy England News
- 29TH NOVEMBER 2024
- 0 COMMENTS
November 2024 Price Concessions 4th Update
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/11/2024) announced the following list of price concessions for November 2024: This is not the final update for November. We are still working with the DHSC to agree
Read more
- Community Pharmacy England News
- 29TH NOVEMBER 2024
- 0 COMMENTS
Budget to cost pharmacies £200 million without mitigation, pharmacy bodies warn
Increases to employers National Insurance contributions and the National Living Wage will cost community pharmacies £200 million a year in unplanned costs, national pharmacy bodies including Community Pharmacy England have warned today. They have told the Government that ‘without mitigation, these additional costs will push many pharmacies more towards insolvency’, leading even more to close
Read more
- Community Pharmacy England News
- 28TH NOVEMBER 2024
- 0 COMMENTS
MHRA Class 4 Medicines Defect Information: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK Ltd)
MHRA Class 4 Medicines Defect Information: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK Ltd) Drug alert number: EL (24)A/58 Date issued: 28 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK
Read more
- Community Pharmacy England News

MHRA Class 4 Medicines Defect Information: Oxybutynin hydrochloride 2.5 mg/5 ml Oral Solution (Brillpharma Limited)

Community Pharmacy England submits proposals for NHS 10-Year Plan

November 2024 Price Concessions Final Update

MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK)

Medicine Supply Notification: Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo

Explained: the introduction of Original Pack Dispensing

MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited)

November 2024 Price Concessions 4th Update

Budget to cost pharmacies £200 million without mitigation, pharmacy bodies warn

MHRA Class 4 Medicines Defect Information: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK Ltd)

Get in Touch

Working together with key healthcare stakeholders, local councils and other healthcare organisations as necessary to ensure that the provision of pharmaceutical services continues to be an integral part of Health and Social Care